Clinical Trial Update: Intended to Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects With Primary Biliary Cholangitis (PBC) [Phase 3]

View source ↗

Summary

Phase 3 trial update assessing seladelpar's effect on normalizing alkaline phosphatase in primary biliary cholangitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Biliary Cholangitis

Drugs mentioned

• Seladelpar (seladelpar)

Snippet

Sponsor: Gilead Sciences | Conditions: Primary Biliary Cholangitis | Phase 3 | Status: COMPLETED